In a bylined article, Intellectual Property partners Brian Nolan and Colleen Tracy James (both New York) examine the CRISPR/Cas9 patent dispute between the University of California, Berkeley (“UC”) and the University of Vienna against the Broad Institute of MIT and Harvard (“Broad Institute”).


To read this complete article visit Law360.
Téléchargements –